Data from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF

MLA

Yvonne Reiss, et al. Data from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF. Apr. 2023. EBSCOhost, https://doi.org/10.1158/2326-6066.c.6550102.

APA

Yvonne Reiss, Karl H. Plate, Kavi Devraj, Stefan Günther, Patrick N. Harter, Ghazaleh Tabatabai, Jens Schittenhelm, Oliver M. Grauer, Reinhard Büttner, Andreas H. Scheel, Martina Deckert, Roland Goldbrunner, Marco Timmer, Astrid Weyerbrock, Matthias Meinhardt, Dietmar Krex, Ulrich Herrlinger, Martin Glas, Volker Seifert, … Mariangela Di Tacchio. (2023). Data from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF. https://doi.org/10.1158/2326-6066.c.6550102

Chicago

Yvonne Reiss, Karl H. Plate, Kavi Devraj, Stefan Günther, Patrick N. Harter, Ghazaleh Tabatabai, Jens Schittenhelm, et al. 2023. “Data from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF,” April. doi:10.1158/2326-6066.c.6550102.